Evidence map›Paper›PMID 41139956›Full record

ArticleBiophysical journal2025

Unmasking complex kinetics in viral entry by inferring hypoexponential models.

Oyinkansola Adenekan, Peter M Kasson

Abstract read
In one paragraph

Article in Biophysical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Oyinkansola AdenekanDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia.
Peter M KassonDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia; Departments of Chemistry & Biochemistry and Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden. Electronic address: kassonlab@gmail.com.

Funding

Simulation-guided spectroscopy and refinement of heterogenous conformational ensemblesR01GM138444 · NIGMS · UNIVERSITY OF VIRGINIA · PI KASSON, PETER M · 2021 to 2024
$1.4M
NIGMS NIH HHS R01 GM138444
6 · The paper itself

Abstract

Single-event completion times, such as are estimated in viral entry, offer both promise and challenge to kinetic interpretation. The promise is that they constrain underlying kinetic models much more efficiently than bulk kinetics, but the challenge is that completion times alone can incompletely determine complex reaction topologies. Gamma distributions or mechanistic models have often been used to estimate kinetic parameters for such data, but the gamma distribution relies on homogenous processes to explain the rate-limiting behavior of the system. Here, we introduce hypoexponential analysis to estimate heterogeneous kinetic processes. We demonstrate that hypoexponential models can indeed estimate rate constants separated by two to three orders of magnitude. We then apply this approach to measurements of SARS-CoV-2 entry, showing that the presence of the ACE2 receptor for SARS-CoV-2 reduces the number of rate-limiting steps but does not change the rates of these kinetic processes. We propose a kinetic model whereby SARS-CoV-2 entry is driven by a mixture of ACE2-accelerated and ACE2-independent spike protein activation events. Inferring such models requires the capability to detect heterogeneous kinetic processes, provided by robust estimation of hypoexponential distributions.

Indexed as

Models, BiologicalSARS-CoV-2Virus InternalizationAngiotensin-Converting Enzyme 2COVID-19HumansKineticsSpike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirus

Identifiers

PMID41139956
PMCPMC12709397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.